Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  LaPointe, Lawrence C ^a,b   Pedersen, Susanne K ^b   Dunne, Robert ^c   Brown, Glenn S ^c   Pimlott, Letitia ^a   Gaur, Snigdha ^b   McEvoy, Aidan ^b   Thomas, Melissa ^b   Wattchow, David ^a   Molloy, Peter L ^c   Young, Graeme P ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b Clinical Genomics Pty Ltd   (Australia)

^c CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN KIAA1199; RNA; UNCLASSIFIED DRUG; KIAA1199 PROTEIN, HUMAN; PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; COLON DIVERTICULOSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROCTITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; UPREGULATION; VALIDATION PROCESS; ADENOMA; BLOOD; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ADENOMA; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856014946     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029059     Document Type: Article

References (33)

1. Cunningham D, Atkin W, Lenz H, Lynch H, Minsky B, et al. (2010) Colorectal cancer. Lancet 375: 1030-47.
2. Atkin W, Edwards R, Kralj-Hans I, Wooldrage K, Hart A R, et al. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375: 1624-33.
3. Mandel J, Church T, Bond J, Snover D, Bradley G, et al. (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. The New England Journal of Medicine 343: 1603-1607.
4. Levin B, Lieberman D, McFarland B, Andrews K, Brooks D, et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134: 1570-1595.
5. Lane J, Chow E, Young G, Good N, Smith A, et al. (2010) Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia. Gastroenterology 139: 1918-26.
6. Young G, Cole S, (2009) Which fecal occult blood test is best to screen for colorectal cancer? Nature clinical practice Gastroenterology & hepatology 6: 140-141.
7. Park D, Ryu S, Kim YH, Lee S, Eun C, et al. (2010) Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. The American Journal of Gastroenterology 105: 2017-2025.
8. Young G, Macrae F, (2003) Neoplastic and nonneoplastic polyps of the colon and rectum. In: Yamada T, Alpers D, Kaplowitz N, editors. Textbook of Gastroenterology, Volume 2, 4th ed 1883-1914 Philadelphia Lippencott Williams & Wilkins.
9. Ransohoff D, (2004) Evaluating discovery-based research: when biologic reasoning cannot work. Gastroenterology 127: 1028-1028.
10. Ransohoff D, (2004) Rules of evidence for cancer molecular-marker discovery and validation. Nature Reviews Cancer 4: 309-314.
11. Simon R, Radmacher M, Dobbin K, McShane L, (2003) Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95: 14-18.
12. Markowitz A, Winawer S, (1999) Screening and surveillance for colorectal cancer. Semin Oncol 26: 485-498.
13. Pepe M, Etzioni R, Feng Z, Potter J, Thompson M, et al. (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061.
14. Sabates-Bellver J, Van der Flier L, de Palo M, Cattaneo E, Maake C, et al. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
15. Birkenkamp-Demtroder K, Christensen L, Olesen S, Frederiksen C, Laiho P, et al. (2002) Gene expression in colorectal cancer. Cancer Research 62: 4352-4363.
16. Jones P, Baylin S, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
17. Chan S, Griffith O, Tai I, Jones S, (2008) Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 17: 543-552.
18. Nannini M, Pantaleo M, Maleddu A, Astolfi A, Formica S, et al. (2009) Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treatment Reviews 35: 201-209.
19. Galamb O, Sipos F, Solymosi N, Spisak S, Krenacs T, et al. (2008) Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev 17: 2835-2845.
20. Matsuzaki S, Tanaka F, Mimori K, Tahara K, Inoue H, et al. (2009) Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer. Ann Surg Oncol 16: 2042-2051.
21. Galamb O, Spisák S, Sipos F, Toth K, Solymosi N, et al. (2010) Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. British Journal of Cancer 102: 765-773.
22. Michishita E, Garcés G, Barrett J, Horikawa Il, (2006) Upregulation of the KIAA1199 gene is associated with cellular mortality. Cancer Letters 239: 71-77.
23. LaPointe L, Dunne R, Brown G, Worthley D, Molly P, et al. (2008) Map of differential transcript expression in the normal human large intestine. Physiological Genomics 33: 50-64.
24. Pradervand S, Paillusson A, Thomas J, Weber J, Wirapati P, et al. (2008) Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3′ expression arrays. Biotechniques 44: 759-762.
25. Livak K, Schmittgen T, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
26. Donia D, Divizia M, Pana A, (2005) Use of armored RNA as a standard to construct a calibration curve for real-time RT-PCR. Journal of virological methods 126: 157-163.
27. Ebert C, Jäger G, Michaelis J, (2010) The Mathematics of Language: 10th and 11th Biennial Conference, MOL 10 1st Edition, VIII 297 Los Angeles, CA, US.
28. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: R80.
29. Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
30. Wettenhall J, Smyth G, (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20: 3705-3706.
31. Bland J, Altman D, (1995) Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346: 1085-1087.
32. Bland J, Altman D, (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170.
33. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.